Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Intern Med. 2014 Jul;25(6):e73-5. doi: 10.1016/j.ejim.2014.02.005. Epub 2014 Mar 11.

Risk of major bleeding and the standard doses of dabigatran.

Author information

  • 1Univ Bordeaux, Inserm U657, F33000 Bordeaux, France; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, I20157 Milan, Italy. Electronic address: stefania.antoniazzi@unimi.it.
  • 2CHU Bordeaux, F33000 Bordeaux, France.
  • 3Regional Centre for Pharmacovigilance, Lombardy Region, via Rosellini 17, I20124 Milan, Italy.
  • 4Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, I20157 Milan, Italy; E. Medea Scientific Institute, I23842 Bosisio Parini, Italy.
  • 5Univ Bordeaux, Inserm U657, F33000 Bordeaux, France; CHU Bordeaux, F33000 Bordeaux, France.

KEYWORDS:

Anticoagulants; Atrial fibrillation; Meta-analysis; Review; Venous thromboembolism

PMID:
24629895
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk